AtriCure Price To Sales Ratio from 2010 to 2024

ATRC Stock  USD 35.68  0.35  0.97%   
AtriCure's Price To Sales Ratio is decreasing over the years with slightly volatile fluctuation. Price To Sales Ratio is expected to dwindle to 3.93. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing AtriCure's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
4.13973427
Current Value
3.93
Quarterly Volatility
319.59789542
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 7.3 M, Total Revenue of 419.2 M or Gross Profit of 315.4 M, as well as many indicators such as Price To Sales Ratio of 3.93, Dividend Yield of 0.0 or PTB Ratio of 3.76. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
  
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

Latest AtriCure's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of AtriCure over the last few years. Price to Sales Ratio is figured by comparing AtriCure stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on AtriCure sales, a figure that is much harder to manipulate than other AtriCure multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. AtriCure's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AtriCure's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.89 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

AtriCure Price To Sales Ratio Regression Statistics

Arithmetic Mean87.77
Geometric Mean6.76
Coefficient Of Variation364.14
Mean Deviation154.03
Median4.85
Standard Deviation319.60
Sample Variance102,143
Range1.2K
R-Value(0.43)
Mean Square Error89,711
R-Squared0.18
Significance0.11
Slope(30.69)
Total Sum of Squares1.4M

AtriCure Price To Sales Ratio History

2024 3.93
2023 4.14
2022 6.14
2021 11.42
2020 11.35
2019 5.29
2018 5.17

About AtriCure Financial Statements

AtriCure stakeholders use historical fundamental indicators, such as AtriCure's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although AtriCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in AtriCure's assets and liabilities are reflected in the revenues and expenses on AtriCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AtriCure. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 4.14  3.93 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out the analysis of AtriCure Correlation against competitors.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83)
Revenue Per Share
9.564
Quarterly Revenue Growth
0.179
Return On Assets
(0.04)
Return On Equity
(0.08)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.